Overview
A combination of inactivated, concentrated, adjuvanted, tissue culture origin equine encephalomyelitis viruses (Eastern and Western), equine herpesviruses types 1 and 4 (EHV-1 and EHV-4), equine influenza virus type H3N8 strains EIV A/eq/Florida/RW/13, EIV A/Equine 2/Kentucky/02 American, EIV A/eq/Richmond/1/07, West Nile virus - flavivirus chimera and tetanus toxoid.
For the vaccination of healthy horses 6 months of age or older against Eastern and Western encephalomyelitis viruses, EIV, EHV-1, EHV-4, tetanus, and West Nile Virus. Duration of immunity has been shown at 6 months for EIV. Shown to decrease virus shedding of EIV, EHV-1 and EHV-4, as well as to decrease encephalitis and viremia caused by West Nile Virus. Foals nursing immune-dams should be vaccinated when maternal antibody levels will allow active immunization.
Dosage: 1 ml IM, repeat in 3-4 weeks. Revaccinate annually.
For the vaccination of healthy horses 6 months of age or older against Eastern and Western encephalomyelitis viruses, EIV, EHV-1, EHV-4, tetanus, and West Nile Virus. Duration of immunity has been shown at 6 months for EIV. Shown to decrease virus shedding of EIV, EHV-1 and EHV-4, as well as to decrease encephalitis and viremia caused by West Nile Virus. Foals nursing immune-dams should be vaccinated when maternal antibody levels will allow active immunization.
Dosage: 1 ml IM, repeat in 3-4 weeks. Revaccinate annually.
Anaphylactoid reactions may occur. Antidote : Epinephrine.
U.S. Lic. No. 165A.
Learn More About Equine Core Vaccines
Manufacturer Label
Safety Data Sheet (SDS)
Prestige 5+WNV Horse Vaccine
14154
A combination of inactivated, concentrated, adjuvanted, tissue culture origin equine encephalomyelitis viruses (Eastern and Western), equine herpesvir… Read More Read More
Features & Benefits
- The first 5-way plus West Nile Virus combination vaccine
- Formulated to minimize reactions and maximize protection
- Produces a booster effect stimulating high, long-lasting protection through a slow release of antigens
Quantity
MAP
Price Each
1 dose w/syringe & needle
Item #14154-1
Case Quantity: 10
Weight: 0.02 lbs
10 dose w/o syringe
Item #14154-2
Case Quantity: 1
Weight: 1.00 lbs
Overview
A combination of inactivated, concentrated, adjuvanted, tissue culture origin equine encephalomyelitis viruses (Eastern and Western), equine herpesviruses types 1 and 4 (EHV-1 and EHV-4), equine influenza virus type H3N8 strains EIV A/eq/Florida/RW/13, EIV A/Equine 2/Kentucky/02 American, EIV A/eq/Richmond/1/07, West Nile virus - flavivirus chimera and tetanus toxoid.
For the vaccination of healthy horses 6 months of age or older against Eastern and Western encephalomyelitis viruses, EIV, EHV-1, EHV-4, tetanus, and West Nile Virus. Duration of immunity has been shown at 6 months for EIV. Shown to decrease virus shedding of EIV, EHV-1 and EHV-4, as well as to decrease encephalitis and viremia caused by West Nile Virus. Foals nursing immune-dams should be vaccinated when maternal antibody levels will allow active immunization.
Dosage: 1 ml IM, repeat in 3-4 weeks. Revaccinate annually.
For the vaccination of healthy horses 6 months of age or older against Eastern and Western encephalomyelitis viruses, EIV, EHV-1, EHV-4, tetanus, and West Nile Virus. Duration of immunity has been shown at 6 months for EIV. Shown to decrease virus shedding of EIV, EHV-1 and EHV-4, as well as to decrease encephalitis and viremia caused by West Nile Virus. Foals nursing immune-dams should be vaccinated when maternal antibody levels will allow active immunization.
Dosage: 1 ml IM, repeat in 3-4 weeks. Revaccinate annually.
Anaphylactoid reactions may occur. Antidote : Epinephrine.
U.S. Lic. No. 165A.
Learn More About Equine Core Vaccines
Manufacturer Label
Safety Data Sheet (SDS)
PBS Animal Health 5-Point Promise – Vaccines Done RIGHT!
Shipping Information for Temperature Sensitive Items
(Vaccines and Other Refrigerated Items)
Product Reviews